X

Vous n'êtes pas connecté

Rubriques :

Maroc Maroc - DRUGS.COM - Pharma Industry News - 05/Sep 14:09

Lung Function Stable Three Years After Hematopoietic Cell Transplant in Sickle Cell

THURSDAY, Sept. 5, 2024 -- Lung function remains stable over three years after hematopoietic cell transplant (HCT) among patients with sickle cell disease (SCD), according to a study published online June 26 in the Annals of the American Thoracic...

Articles similaires

Sorry! Image not available at this time

Risk for Venous Thromboembolism Up for Those With Sickle Cell Trait

drugs.com - 12/Sep 21:28

THURSDAY, Sept. 12, 2024 -- Individuals with sickle cell trait (SCT) have an increased risk for venous thromboembolism (VTE), according to a study...

Sorry! Image not available at this time

Risk for Venous Thromboembolism Up for Those With Sickle Cell Trait

drugs.com - 12/Sep 21:28

THURSDAY, Sept. 12, 2024 -- Individuals with sickle cell trait (SCT) have an increased risk for venous thromboembolism (VTE), according to a study...

Sorry! Image not available at this time

Perioperative Nivolumab Beneficial for Resectable NSCLC

drugs.com - 12/Sep 15:09

THURSDAY, Sept. 12, 2024 -- For patients with resectable non-small-cell lung cancer (NSCLC), perioperative nivolumab is associated with event-free...

Sorry! Image not available at this time

RSV Vaccination Effective Against Hospitalization in Patients 60 Years and Older

drugs.com - 05/Sep 22:36

THURSDAY, Sept. 5, 2024 -- For older adults, respiratory syncytial virus (RSV) vaccination is effective against RSV hospitalization, according to a...

Sorry! Image not available at this time

Seres Therapeutics Reports SER-155 Phase 1b Placebo-Controlled Cohort 2 Study Safety and Clinical Results in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT)

healthtechzone.com - 12/Sep 11:00

Sorry! Image not available at this time

Seres Therapeutics Reports SER-155 Phase 1b Placebo-Controlled Cohort 2 Study Safety and Clinical Results in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT)

healthtechzone.com - 12/Sep 11:00

Sorry! Image not available at this time

Risk for Second Primary Cancer May Be No Higher With CAR T-Cell Versus Standard of Care

drugs.com - 12/Sep 15:09

THURSDAY, Sept. 12, 2024 -- The overall second primary malignancy (SPM) point estimate was 5.8 percent for patients receiving chimeric antigen...

Sorry! Image not available at this time

Psychological Illness, CVD Risk Increased for Relatives, Spouses of Cancer Patients

drugs.com - 09/Sep 16:02

MONDAY, Sept. 9, 2024 -- Cancer diagnosis is associated with an increased risk for psychological illness and cardiovascular disease among...

Sorry! Image not available at this time

Outdoor Nighttime Light Exposure Linked to Prevalence of Alzheimer Disease

drugs.com - 06/Sep 21:53

FRIDAY, Sept. 6, 2024 -- Exposure to outdoor nighttime light is associated with the prevalence of Alzheimer disease (AD), especially among those aged...

Sorry! Image not available at this time

Weekly Mobile Phone Use Increases Risk for New Cardiovascular Disease Over Time

drugs.com - 05/Sep 15:09

THURSDAY, Sept. 5, 2024 -- Weekly mobile phone usage is positively associated with incident cardiovascular disease (CVD) risk over 12 years, according...

Les derniers communiqués